chrX-38411900-C-T
Variant names:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM2BP6_Very_Strong
The NM_000531.6(OTC):c.906C>T(p.His302His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000331 in 1,209,152 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.0000018 ( 0 hom. 0 hem. )
Consequence
OTC
NM_000531.6 synonymous
NM_000531.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.971
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant X-38411900-C-T is Benign according to our data. Variant chrX-38411900-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1096485.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.906C>T | p.His302His | synonymous_variant | Exon 9 of 10 | ENST00000039007.5 | NP_000522.3 | |
OTC | NM_001407092.1 | c.906C>T | p.His302His | synonymous_variant | Exon 11 of 12 | NP_001394021.1 | ||
OTC | XM_017029556.2 | c.*39C>T | downstream_gene_variant | XP_016885045.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTC | ENST00000039007.5 | c.906C>T | p.His302His | synonymous_variant | Exon 9 of 10 | 1 | NM_000531.6 | ENSP00000039007.4 | ||
ENSG00000250349 | ENST00000465127.1 | c.172-254221C>T | intron_variant | Intron 3 of 8 | 5 | ENSP00000417050.1 | ||||
OTC | ENST00000643344.1 | n.*656C>T | non_coding_transcript_exon_variant | Exon 10 of 11 | ENSP00000496606.1 | |||||
OTC | ENST00000643344.1 | n.*656C>T | 3_prime_UTR_variant | Exon 10 of 11 | ENSP00000496606.1 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112053Hom.: 0 Cov.: 23 AF XY: 0.0000292 AC XY: 1AN XY: 34209
GnomAD3 genomes
AF:
AC:
2
AN:
112053
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34209
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000546 AC: 1AN: 183267Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67787
GnomAD3 exomes
AF:
AC:
1
AN:
183267
Hom.:
AF XY:
AC XY:
0
AN XY:
67787
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1097099Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 362493
GnomAD4 exome
AF:
AC:
2
AN:
1097099
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
362493
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112053Hom.: 0 Cov.: 23 AF XY: 0.0000292 AC XY: 1AN XY: 34209
GnomAD4 genome
AF:
AC:
2
AN:
112053
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34209
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Benign:2
Sep 04, 2023
All of Us Research Program, National Institutes of Health
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Aug 20, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 12
DS_AL_spliceai
Position offset: -38
Find out detailed SpliceAI scores and Pangolin per-transcript scores at